Two patients received gastrectomy due to a neuroendocrine tumor (NET), two patients presented with a mixed adenoneuroendocrine carcinoma (MANEC), one patient presented with a gastric metastasis of malignant melanoma, and one patient received prophylactic gastrectomy due to a CDH-1 gene defect. This evidence concerns the gene CDH1 and melanoma.